Humanetics Pharmaceuticals Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $8.5M

  • Investors
  • 6

Humanetics Pharmaceuticals General Information

Description

Operator of a pharmaceutical company intended to develop and commercialize products to enhance human health and well-being. The company focuses on the discovery and early development of drugs that can protect warfighters from the harmful effects of radiation developed for multiple indications utilizing a variety of patented formulations, enabling clinicians to be provided with improved outcomes for cancer patients receiving radiation treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 261 School Avenue
  • Suite 210
  • Excelsior, MN 55331
  • United States
+1 (952)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Pharmaceuticals
Corporate Office
  • 261 School Avenue
  • Suite 210
  • Excelsior, MN 55331
  • United States
+1 (952)

Humanetics Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Humanetics Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Debt - General 01-Sep-2025 $8.5M Completed Clinical Trials - Phase 2
11. Later Stage VC Completed Clinical Trials - Phase 2
10. Grant 01-Jan-2023 Completed Clinical Trials - Phase 2
9. Grant 21-Jun-2022 Completed Clinical Trials - Phase 2
8. Grant 01-Jan-2022 Completed Clinical Trials - Phase 2
7. Grant 31-Dec-2019 Completed Clinical Trials - Phase 2
6. Grant 01-Apr-2019 Completed Clinical Trials - Phase 2
5. Grant 01-Dec-2017 Completed Clinical Trials - Phase 2
4. Grant 01-Jan-2016 $597K Completed Clinical Trials - Phase 2
3. Grant 01-Jan-2014 $1.72M Completed Clinical Trials - Phase 2
To view Humanetics Pharmaceuticals’s complete valuation and funding history, request access »

Humanetics Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop and commercialize products to enhance human health and well-bei
Other Healthcare Technology Systems
Excelsior, MN
18 As of 2025

Carlsbad, CA

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Humanetics Pharmaceuticals Competitors (31)

One of Humanetics Pharmaceuticals’s 31 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
CSL Behring (Biotechnology) Corporation Vienna, Austria
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Cantex Pharmaceuticals Formerly VC-backed Weston, FL
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 31 competitors. Get the full list »

Humanetics Pharmaceuticals Patents

Humanetics Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026169634-A1 Process for the synthesis of genistein Pending 04-Feb-2025
US-20240415802-A1 Genistein for asthma treatment Pending 14-Mar-2022
US-12797357-B2 Nanoparticle isoflavone compositions and methods of making and using the same Active 10-Feb-2022
CA-3207497-A1 Genistein treatment of inflammatory and immunological disorders Pending 11-Jan-2021
EP-4274552-A1 Genistein treatment of inflammatory and immunological disorders Pending 11-Jan-2021 A61K31/352
To view Humanetics Pharmaceuticals’s complete patent history, request access »

Humanetics Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Humanetics Pharmaceuticals Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
United States Department of War Government
National Institutes of Health Government
National Aeronautics and Space Administration Government
National Cancer Institute Government
National Institute Of Allergy and Infectious Diseases Government
You’re viewing 5 of 6 investors. Get the full list »

Humanetics Pharmaceuticals Investments (1)

Humanetics Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with DSM Nutritional Products (Drug Manufacturing Assets in the United States). The deal was made on 19-Feb-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DSM Nutritional Products (Drug Manufacturing Assets in the United States) 19-Feb-2020 Corporate Asset Purchase Buildings and Property
To view Humanetics Pharmaceuticals’s complete investments history, request access »

Humanetics Pharmaceuticals FAQs

  • When was Humanetics Pharmaceuticals founded?

    Humanetics Pharmaceuticals was founded in 1988.

  • Where is Humanetics Pharmaceuticals headquartered?

    Humanetics Pharmaceuticals is headquartered in Excelsior, MN.

  • What is the size of Humanetics Pharmaceuticals?

    Humanetics Pharmaceuticals has 18 total employees.

  • What industry is Humanetics Pharmaceuticals in?

    Humanetics Pharmaceuticals’s primary industry is Other Healthcare Technology Systems.

  • Is Humanetics Pharmaceuticals a private or public company?

    Humanetics Pharmaceuticals is a Private company.

  • What is Humanetics Pharmaceuticals’s current revenue?

    The current revenue for Humanetics Pharmaceuticals is .

  • How much funding has Humanetics Pharmaceuticals raised over time?

    Humanetics Pharmaceuticals has raised $8.5M.

  • Who are Humanetics Pharmaceuticals’s investors?

    United States Department of War, National Institutes of Health, National Aeronautics and Space Administration, National Cancer Institute, and National Institute Of Allergy and Infectious Diseases are 5 of 6 investors who have invested in Humanetics Pharmaceuticals.

  • Who are Humanetics Pharmaceuticals’s competitors?

    Renova Therapeutics, CSL Behring (Biotechnology), Cristal Therapeutics, Cantex Pharmaceuticals, and Genentech are some of the 31 competitors of Humanetics Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process